A citation-based method for searching scientific literature

Hanjie Li, Anne M van der Leun, Ido Yofe, Yaniv Lubling, Dikla Gelbard-Solodkin, Alexander C J van Akkooi, Marlous van den Braber, Elisa A Rozeman, John B A G Haanen, Christian U Blank, Hugo M Horlings, Eyal David, Yael Baran, Akhiad Bercovich, Aviezer Lifshitz, Ton N Schumacher, Amos Tanay, Ido Amit. Cell 2019
Times Cited: 258



Moshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, John P Ray, Carl G de Boer, Russell W Jenkins, David J Lieb, Jonathan H Chen, Dennie T Frederick, Michal Barzily-Rokni, Samuel S Freeman, Alexandre Reuben, Paul J Hoover, Alexandra-Chloé Villani, Elena Ivanova, Andrew Portell, Patrick H Lizotte, Amir R Aref, Jean-Pierre Eliane, Marc R Hammond, Hans Vitzthum, Shauna M Blackmon, Bo Li, Vancheswaran Gopalakrishnan, Sangeetha M Reddy, Zachary A Cooper, Cloud P Paweletz, David A Barbie, Anat Stemmer-Rachamimov, Keith T Flaherty, Jennifer A Wargo, Genevieve M Boland, Ryan J Sullivan, Gad Getz, Nir Hacohen. Cell 2018
Times Cited: 448




List of shared articles



Times cited

Ectopic Tcf1 expression instills a stem-like program in exhausted CD8+ T cells to enhance viral and tumor immunity.
Qiang Shan, Sheng'en Hu, Xia Chen, Derek B Danahy, Vladimir P Badovinac, Chongzhi Zang, Hai-Hui Xue. Cell Mol Immunol 2021
15

Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells.
Faezzah Baharom, Ramiro A Ramirez-Valdez, Kennedy K S Tobin, Hidehiro Yamane, Charles-Antoine Dutertre, Ahad Khalilnezhad, Glennys V Reynoso, Vincent L Coble, Geoffrey M Lynn, Matthew P Mulè,[...]. Nat Immunol 2021
14

CD147 regulates antitumor CD8+ T-cell responses to facilitate tumor-immune escape.
Yatong Chen, Jing Xu, Xiaodong Wu, Hui Yao, Zhou Yan, Ting Guo, Wenjing Wang, Peixiao Wang, Yu Li, Xiangmin Yang,[...]. Cell Mol Immunol 2021
2

BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes.
Lukas Peiffer, Farnoush Farahpour, Ashwin Sriram, Ivelina Spassova, Daniel Hoffmann, Linda Kubat, Patrizia Stoitzner, Thilo Gambichler, Antje Sucker, Selma Ugurel,[...]. Cancer Immunol Immunother 2021
1

Understanding the tumor microenvironment for effective immunotherapy.
Habib Sadeghi Rad, James Monkman, Majid E Warkiani, Rahul Ladwa, Ken O'Byrne, Nima Rezaei, Arutha Kulasinghe. Med Res Rev 2021
8

Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells.
Anthony Kusnadi, Ciro Ramírez-Suástegui, Vicente Fajardo, Serena J Chee, Benjamin J Meckiff, Hayley Simon, Emanuela Pelosi, Grégory Seumois, Ferhat Ay, Pandurangan Vijayanand,[...]. Sci Immunol 2021
34

Contribution of resident and circulating precursors to tumor-infiltrating CD8+ T cell populations in lung cancer.
Paul Gueguen, Christina Metoikidou, Thomas Dupic, Myriam Lawand, Christel Goudot, Sylvain Baulande, Sonia Lameiras, Olivier Lantz, Nicolas Girard, Agathe Seguin-Givelet,[...]. Sci Immunol 2021
4

Melanoma Single-Cell Biology in Experimental and Clinical Settings.
Hans Binder, Maria Schmidt, Henry Loeffler-Wirth, Lena Suenke Mortensen, Manfred Kunz. J Clin Med 2021
0

Melanoma models for the next generation of therapies.
E Elizabeth Patton, Kristen L Mueller, David J Adams, Niroshana Anandasabapathy, Andrew E Aplin, Corine Bertolotto, Marcus Bosenberg, Craig J Ceol, Christin E Burd, Ping Chi,[...]. Cancer Cell 2021
7

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy.
Riyao Yang, Linlin Sun, Ching-Fei Li, Yu-Han Wang, Jun Yao, Hui Li, Meisi Yan, Wei-Chao Chang, Jung-Mao Hsu, Jong-Ho Cha,[...]. Nat Commun 2021
20

Intratumoral heterogeneity in cancer progression and response to immunotherapy.
Ilio Vitale, Efrat Shema, Sherene Loi, Lorenzo Galluzzi. Nat Med 2021
33

The current landscape of single-cell transcriptomics for cancer immunotherapy.
Puneeth Guruprasad, Yong Gu Lee, Ki Hyun Kim, Marco Ruella. J Exp Med 2021
6

Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity.
Allan Relecom, Maysaloun Merhi, Varghese Inchakalody, Shahab Uddin, Darawan Rinchai, Davide Bedognetti, Said Dermime. J Exp Clin Cancer Res 2021
0

Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment.
Xianwen Ren, Lei Zhang, Yuanyuan Zhang, Ziyi Li, Nathan Siemers, Zemin Zhang. Annu Rev Immunol 2021
6

Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment.
Rongqun Guo, Mengdie Lü, Fujiao Cao, Guanghua Wu, Fengcai Gao, Haili Pang, Yadan Li, Yinyin Zhang, Haizhou Xing, Chunyan Liang,[...]. Biomark Res 2021
3

Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells.
Liliana E Lucca, Pierre-Paul Axisa, Benjamin Lu, Brian Harnett, Shlomit Jessel, Le Zhang, Khadir Raddassi, Lin Zhang, Kelly Olino, James Clune,[...]. J Exp Med 2021
3

Progressive immune dysfunction with advancing disease stage in renal cell carcinoma.
David A Braun, Kelly Street, Kelly P Burke, David L Cookmeyer, Thomas Denize, Christina B Pedersen, Satyen H Gohil, Nicholas Schindler, Lucas Pomerance, Laure Hirsch,[...]. Cancer Cell 2021
7

EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia.
Laura Llaó-Cid, Philipp M Roessner, Vicente Chapaprieta, Selcen Öztürk, Tobias Roider, Marie Bordas, Ana Izcue, Dolors Colomer, Sascha Dietrich, Stephan Stilgenbauer,[...]. Leukemia 2021
2


Predicting recognition between T cell receptors and epitopes with TCRGP.
Emmi Jokinen, Jani Huuhtanen, Satu Mustjoki, Markus Heinonen, Harri Lähdesmäki. PLoS Comput Biol 2021
6

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade.
Romain Banchereau, Avantika S Chitre, Alexis Scherl, Thomas D Wu, Namrata S Patil, Patricia de Almeida, Edward E Kadel Iii, Shravan Madireddi, Amelia Au-Yeung, Chikara Takahashi,[...]. J Immunother Cancer 2021
2

Microenvironmental regulation of tumour immunity and response to immunotherapy.
Mark M Kockx, Mark McCleland, Hartmut Koeppen. J Pathol 2021
3

Distinct Biomarker Profiles and TCR Sequence Diversity Characterize the Response to PD-L1 Blockade in a Mouse Melanoma Model.
Rajaa El Meskini, Devon Atkinson, Alan Kulaga, Abdalla Abdelmaksoud, Michelle Gumprecht, Nathan Pate, Susana Hayes, Michael Oberst, Ian M Kaplan, Patrick Raber,[...]. Mol Cancer Res 2021
0

Tim-3 adaptor protein Bat3 is a molecular checkpoint of T cell terminal differentiation and exhaustion.
Chen Zhu, Karen O Dixon, Kathleen Newcomer, Guangxiang Gu, Sheng Xiao, Sarah Zaghouani, Markus A Schramm, Chao Wang, Huiyuan Zhang, Kouichiro Goto,[...]. Sci Adv 2021
0

A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer.
Ayse Bassez, Hanne Vos, Laurien Van Dyck, Giuseppe Floris, Ingrid Arijs, Christine Desmedt, Bram Boeckx, Marlies Vanden Bempt, Ines Nevelsteen, Kathleen Lambein,[...]. Nat Med 2021
9

Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer.
Milena Hornburg, Mélanie Desbois, Shan Lu, Yinghui Guan, Amy A Lo, Susan Kaufman, Ashley Elrod, Alina Lotstein, Teresa M DesRochers, Jose L Munoz-Rodriguez,[...]. Cancer Cell 2021
6

Interpretation of T cell states from single-cell transcriptomics data using reference atlases.
Massimo Andreatta, Jesus Corria-Osorio, Sören Müller, Rafael Cubas, George Coukos, Santiago J Carmona. Nat Commun 2021
4

Intratumoral CXCR5+CD8+T associates with favorable clinical outcomes and immunogenic contexture in gastric cancer.
Jieti Wang, Ruochen Li, Yifan Cao, Yun Gu, Hanji Fang, Yuchao Fei, Kunpeng Lv, Xudong He, Chao Lin, Hao Liu,[...]. Nat Commun 2021
1

Mechanism of action of PD-1 receptor/ligand targeted cancer immunotherapy.
Jannie Borst, Julia Busselaar, Douwe M T Bosma, Ferry Ossendorp. Eur J Immunol 2021
2


Immu-Mela: An open resource for exploring immunotherapy-related multidimensional genomic profiles in melanoma.
Jing Yang, Shilin Zhao, Jing Wang, Quanhu Sheng, Qi Liu, Yu Shyr. J Genet Genomics 2021
0

Type I Interferon Transcriptional Network Regulates Expression of Coinhibitory Receptors in Human T cells.
David Hafler, Tomokazu Sumida, Shai Dulberg, Jonas Schupp, Helen Stillwell, Pierre-Paul Axisa, Michela Comi, Matthew Lincoln, Avraham Unterman, Naftali Kaminski,[...]. Res Sq 2021
0

Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity.
Jenna L Collier, Sarah A Weiss, Kristen E Pauken, Debattama R Sen, Arlene H Sharpe. Nat Immunol 2021
1


Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy.
Simon Eschweiler, James Clarke, Ciro Ramírez-Suástegui, Bharat Panwar, Ariel Madrigal, Serena J Chee, Ioannis Karydis, Edwin Woo, Aiman Alzetani, Somaia Elsheikh,[...]. Nat Immunol 2021
2

Resident and circulating memory T cells persist for years in melanoma patients with durable responses to immunotherapy.
Jichang Han, Yanding Zhao, Keisuke Shirai, Aleksey Molodtsov, Fred W Kolling, Jan L Fisher, Peisheng Zhang, Shaofeng Yan, Tyler G Searles, Justin M Bader,[...]. Nat Cancer 2021
6

Novel anti-GARP antibody DS-1055a augments anti-tumor immunity by depleting highly suppressive GARP+ regulatory T cells.
Kazuki Satoh, Yoichi Kobayashi, Kaori Fujimaki, Shinko Hayashi, Saori Ishida, Daisuke Sugiyama, Takahiko Sato, Kyungtaek Lim, Megumi Miyamoto, Shiho Kozuma,[...]. Int Immunol 2021
0

CD8+ T cell differentiation and dysfunction in cancer.
Mary Philip, Andrea Schietinger. Nat Rev Immunol 2021
2

CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment.
Mauro Di Pilato, Raphael Kfuri-Rubens, Jasper N Pruessmann, Aleksandra J Ozga, Marius Messemaker, Bruno L Cadilha, Ramya Sivakumar, Chiara Cianciaruso, Ross D Warner, Francesco Marangoni,[...]. Cell 2021
3